CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient iPSC-derived RPE Cells. Navneet S, Rohrer B. Invest Ophthalmol Vis Sci 2026;67:9.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Navneet S, Rohrer B. CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient iPSC-derived RPE Cells. Invest Ophthalmol Vis Sci 2026;67:9.
PMID: 41631752